Engineering microbial therapeutics for metabolic disorders: synthetic biology strategies and future direction.

Metabolic disorders, including type 2 diabetes mellitus, obesity, metabolic dysfunction-associated steatohepatitis, etc., are an escalating global health challenge with substantial clinical and socio-economic burdens. Conventional pharmacological the…

Preview only. Read the full abstract at the source